SCHEMBL2406379

SCHEMBL2406379

OB(c1ccccc1)c1cc(B(O)c2ccccc2)cc(B(O)c2ccccc2)c1

nearest known ligand 0.82

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPV6 Q9H1D0 7/20 0.82
ORAI1 Q96D31 6/20 0.82
ORAI2 Q96SN7 6/20 0.82
ORAI3 Q9BRQ5 6/20 0.82
PCSK9 Q8NBP7 2/20 0.82
ENPP2 Q13822 3/20 0.55
CA4 P22748 1/20 0.55
CA6 P23280 1/20 0.55
CA5A P35218 1/20 0.55
CA7 P43166 1/20 0.55
CA14 Q9ULX7 1/20 0.55
CA5B Q9Y2D0 1/20 0.55
MGLL Q99685 2/20 0.46
CA1 P00915 3/20 0.40
CA2 P00918 3/20 0.40
ALDH1A1 P00352 2/20 0.37
KDM4E B2RXH2 1/20 0.37
ATM Q13315 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2406124 0.92 TRPV6 (0.78) TRPV6ORAI1ORAI2ORAI3PCSK9
Diphenyl Borinic Acid SCHEMBL40601 0.91 TRPV6 (1.00) TRPV6ORAI1ORAI2ORAI3PCSK9
SCHEMBL2412647 0.88 TRPV6 (0.93) TRPV6ORAI1ORAI2ORAI3PCSK9
Diphenyl Borinic Acid SCHEMBL28080639 0.88 TRPV6 (0.93) TRPV6ORAI1ORAI2ORAI3PCSK9
Diphenyl Borinic Acid SCHEMBL20694919 0.80 TRPV6 (0.78) TRPV6ORAI1ORAI2ORAI3PCSK9
SCHEMBL2407457 0.78 TRPV6 (0.74) TRPV6ORAI1ORAI2ORAI3PCSK9
SCHEMBL2405808 0.77 TRPV6 (0.72) TRPV6ORAI1ORAI2ORAI3PCSK9
SCHEMBL17698481 0.76 TRPV6 (0.70) TRPV6ORAI1ORAI2ORAI3PCSK9
SCHEMBL3275714 0.76 TRPV6 (0.70) TRPV6ORAI1ORAI2ORAI3PCSK9
SCHEMBL12266144 0.76 TRPV6 (0.80) TRPV6ORAI1ORAI2ORAI3PCSK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8853424-B2 Protein cross-linking inhibitor JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) 2014-10-07 US disclosed
US-8853424-B2 Protein cross-linking inhibitor JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) 2014-10-07 US disclosed
US-8853424-B2 Protein cross-linking inhibitor JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) 2014-10-07 US disclosed
US-20110212919-A1 PROTEIN CROSS-LINKING INHIBITOR JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) 2011-09-01 US disclosed
US-20110212919-A1 PROTEIN CROSS-LINKING INHIBITOR JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) 2011-09-01 US disclosed
US-20110212919-A1 PROTEIN CROSS-LINKING INHIBITOR JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) 2011-09-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110212919-A1 PROTEIN CROSS-LINKING INHIBITOR BAZ2B, PRMT1, BRIX1 TRPV6 4868/4885ORAI1 4605/4885ORAI2 3906/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.